Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Campylobacter curvus 50S ribosomal protein L10 (rplJ) CSB-YP416874CWB
CSB-EP416874CWB
CSB-BP416874CWB
CSB-MP416874CWB
CSB-EP416874CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP416875CWB
CSB-EP416875CWB
CSB-BP416875CWB
CSB-MP416875CWB
CSB-EP416875CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus ATP synthase gamma chain (atpG) CSB-YP416876CWB
CSB-EP416876CWB
CSB-BP416876CWB
CSB-MP416876CWB
CSB-EP416876CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Phosphate acyltransferase (plsX) CSB-YP416877CWB
CSB-EP416877CWB
CSB-BP416877CWB
CSB-MP416877CWB
CSB-EP416877CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Adenylosuccinate synthetase (purA) CSB-YP416878CWB
CSB-EP416878CWB
CSB-BP416878CWB
CSB-MP416878CWB
CSB-EP416878CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Enolase (eno) CSB-YP416879CWB
CSB-EP416879CWB
CSB-BP416879CWB
CSB-MP416879CWB
CSB-EP416879CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L15 (rplO) CSB-YP416880CWB
CSB-EP416880CWB
CSB-BP416880CWB
CSB-MP416880CWB
CSB-EP416880CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus 50S ribosomal protein L2 (rplB) CSB-YP416881CWB
CSB-EP416881CWB
CSB-BP416881CWB
CSB-MP416881CWB
CSB-EP416881CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter curvus Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP416882CWB
CSB-EP416882CWB
CSB-BP416882CWB
CSB-MP416882CWB
CSB-EP416882CWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei 3-dehydroquinate dehydratase (aroQ) CSB-YP416883CWE
CSB-EP416883CWE
CSB-BP416883CWE
CSB-MP416883CWE
CSB-EP416883CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP416884CWE
CSB-EP416884CWE
CSB-BP416884CWE
CSB-MP416884CWE
CSB-EP416884CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Uridylate kinase (pyrH) CSB-YP416885CWE
CSB-EP416885CWE
CSB-BP416885CWE
CSB-MP416885CWE
CSB-EP416885CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP416886CWE
CSB-EP416886CWE
CSB-BP416886CWE
CSB-MP416886CWE
CSB-EP416886CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Probable transcriptional regulatory protein JJD26997_0557 (JJD26997_0557) CSB-YP416887CWE
CSB-EP416887CWE
CSB-BP416887CWE
CSB-MP416887CWE
CSB-EP416887CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Aspartate carbamoyltransferase (pyrB) CSB-YP416888CWE
CSB-EP416888CWE
CSB-BP416888CWE
CSB-MP416888CWE
CSB-EP416888CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP416889CWE
CSB-EP416889CWE
CSB-BP416889CWE
CSB-MP416889CWE
CSB-EP416889CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei 3-dehydroquinate synthase (aroB) CSB-YP416890CWE
CSB-EP416890CWE
CSB-BP416890CWE
CSB-MP416890CWE
CSB-EP416890CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Putative membrane protein insertion efficiency factor (JJD26997_0822) CSB-YP416891CWE
CSB-EP416891CWE
CSB-BP416891CWE
CSB-MP416891CWE
CSB-EP416891CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Alanine racemase (alr) CSB-YP416892CWE
CSB-EP416892CWE
CSB-BP416892CWE
CSB-MP416892CWE
CSB-EP416892CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. doylei Bifunctional protein FolD (folD) CSB-YP416893CWE
CSB-EP416893CWE
CSB-BP416893CWE
CSB-MP416893CWE
CSB-EP416893CWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>